186 related articles for article (PubMed ID: 20980262)
1. Single domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domain.
Tanaka T; Sewell H; Waters S; Phillips SE; Rabbitts TH
J Biol Chem; 2011 Feb; 286(5):3707-16. PubMed ID: 20980262
[TBL] [Abstract][Full Text] [Related]
2. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
[TBL] [Abstract][Full Text] [Related]
3. Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia.
Appert A; Nam CH; Lobato N; Priego E; Miguel RN; Blundell T; Drynan L; Sewell H; Tanaka T; Rabbitts T
Cancer Res; 2009 Jun; 69(11):4784-90. PubMed ID: 19487290
[TBL] [Abstract][Full Text] [Related]
4. An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions.
Nam CH; Lobato MN; Appert A; Drynan LF; Tanaka T; Rabbitts TH
Oncogene; 2008 Aug; 27(36):4962-8. PubMed ID: 18438427
[TBL] [Abstract][Full Text] [Related]
5. Intracellular antibody capture (IAC) methods for single domain antibodies.
Tanaka T; Rabbitts TH
Methods Mol Biol; 2012; 911():151-73. PubMed ID: 22886251
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of a tethered Lmo2(LIM2) /Ldb1(LID) complex.
Dastmalchi S; Wilkinson-White L; Kwan AH; Gamsjaeger R; Mackay JP; Matthews JM
Protein Sci; 2012 Nov; 21(11):1768-74. PubMed ID: 22936624
[TBL] [Abstract][Full Text] [Related]
7. Identification of the key LMO2-binding determinants on Ldb1.
Ryan DP; Sunde M; Kwan AH; Marianayagam NJ; Nancarrow AL; Vanden Hoven RN; Thompson LS; Baca M; Mackay JP; Visvader JE; Matthews JM
J Mol Biol; 2006 May; 359(1):66-75. PubMed ID: 16616188
[TBL] [Abstract][Full Text] [Related]
8. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
[TBL] [Abstract][Full Text] [Related]
9. Purification, crystallization and preliminary X-ray analysis of a fusion of the LIM domains of LMO2 and the LID domain of Ldb1.
El Omari K; Porcher C; Mancini EJ
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1466-9. PubMed ID: 21045296
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4.
Deane JE; Mackay JP; Kwan AH; Sum EY; Visvader JE; Matthews JM
EMBO J; 2003 May; 22(9):2224-33. PubMed ID: 12727888
[TBL] [Abstract][Full Text] [Related]
11. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
[TBL] [Abstract][Full Text] [Related]
12. Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds.
Canning P; Bataille C; Bery N; Milhas S; Hayes A; Raynaud F; Miller A; Rabbitts T
J Immunol Methods; 2021 Jul; 494():113051. PubMed ID: 33794223
[TBL] [Abstract][Full Text] [Related]
13. Design, production and characterization of FLIN2 and FLIN4: the engineering of intramolecular ldb1:LMO complexes.
Deane JE; Sum E; Mackay JP; Lindeman GJ; Visvader JE; Matthews JM
Protein Eng; 2001 Jul; 14(7):493-9. PubMed ID: 11522923
[TBL] [Abstract][Full Text] [Related]
14. LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.
Layer JH; Alford CE; McDonald WH; Davé UP
Mol Cell Biol; 2016 Feb; 36(3):488-506. PubMed ID: 26598604
[TBL] [Abstract][Full Text] [Related]
15. Homo-binding character of LMO2 isoforms and their both synergic and antagonistic functions in regulating hematopoietic-related target genes.
Sun W; Shen WW; Yang S; Hu F; Gao Y; Qiao YH; Zhu TH
J Biomed Sci; 2010 Mar; 17(1):22. PubMed ID: 20346173
[TBL] [Abstract][Full Text] [Related]
16. A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2.
Bery N; Bataille CJR; Russell A; Hayes A; Raynaud F; Milhas S; Anand S; Tulmin H; Miller A; Rabbitts TH
Sci Adv; 2021 Apr; 7(15):. PubMed ID: 33837087
[TBL] [Abstract][Full Text] [Related]
17. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
[TBL] [Abstract][Full Text] [Related]
18. Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell acute lymphoblastic leukemia.
Li L; Mitra A; Cui K; Zhao B; Choi S; Lee JY; Stamos DB; El-Khoury D; Warzecha C; Pfeifer K; Hardwick J; Zhao K; Venters B; Davé UP; Love PE
Blood; 2020 Jun; 135(25):2252-2265. PubMed ID: 32181817
[TBL] [Abstract][Full Text] [Related]
19. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.
Yamada Y; Warren AJ; Dobson C; Forster A; Pannell R; Rabbitts TH
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3890-5. PubMed ID: 9520463
[TBL] [Abstract][Full Text] [Related]
20. The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish.
Patterson LJ; Gering M; Eckfeldt CE; Green AR; Verfaillie CM; Ekker SC; Patient R
Blood; 2007 Mar; 109(6):2389-98. PubMed ID: 17090656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
